Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001181431-10-062275)

Filing Details

Accession Number:: 0001181431-10-062275
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2010-12-16 17:33:50
Reporting Period:: 2010-12-14

Filing Date:: 2010-12-16
Accepted Time:: 2010-12-16 17:33:50
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
926617	Vermillion Inc.	VRML	In Vitro & In Vivo Diagnostic Substances (2835)	330595156

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1276085	S Gail Page	C/O Vermillion,Inc. 12117 Bee Caves Road Building Two, Suite 100 Austin TX 78738	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2010-12-14	45,000	$5.92	139,907	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

The proceeds of the sale of the 45,000 shares of common stock described in this form are intended to cover the tax liability incurred by Gail Page on the 128,580 shares distributed to her on December 10, 2010.